Basit öğe kaydını göster

dc.contributor.authorEkinci Akdemir, F.N. and Yildirim, S. and Kandemir, F.M. and Tanyeli, A. and Küçükler, S. and Bahaeddin Dortbudak, M.
dc.date.accessioned2021-04-08T12:07:12Z
dc.date.available2021-04-08T12:07:12Z
dc.date.issued2019
dc.identifier10.1080/13813455.2019.1630652
dc.identifier.issn13813455
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85068163764&doi=10.1080%2f13813455.2019.1630652&partnerID=40&md5=c45a120020c1786785f492402595510e
dc.identifier.urihttp://acikerisim.bingol.edu.tr/handle/20.500.12898/4242
dc.description.abstractThe present study aims to examine the possible beneficial effects of gallic acid (GA) against doxorubicin-induced cardiotoxicity in the experimental model. Rats were weighed and divided into groups. Groups as following; control, gallic acid (GA), doxorubicin (DOX) and GA + DOX groups. At the end of the experiment, rats were sacrificed and heart tissue removed. The tissues were analysed in terms of biochemical (MDA, SOD, CAT, GSH, GPx), pathological (hyaline degeneration, Zenkerin necrosis, hyperaemia) and immunohistochemical (TNF-α, Cox-2). MDA level decreased and antioxidant enzyme activities increased in GA + DOX group compared to doxorubicin group. TNF-α, Cox-2 expression levels were severe in the DOX group. Also, pathologic tissue damage in heart tissue increased due to doxorubicin. Additionally, pathologic tissue damage and TNF-α, Cox-2 expression levels decreased in GA + DOX group. According to our findings, GA has protective effect against doxorubicin-induced cardiotoxicity. © 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group.
dc.language.isoEnglish
dc.sourceArchives of Physiology and Biochemistry
dc.titleProtective effects of gallic acid on doxorubicin-induced cardiotoxicity; an experimantal study


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster